Calliditas Therapeutics Ab ADR (CALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2019 | 03-2019 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 56,696 | 65,116 |
| Other current assets | 17,122 | 831 |
| TOTAL | $73,818 | $65,947 |
| Non-Current Assets | ||
| PPE Net | 786 | 43 |
| Investments And Advances | 283 | 37 |
| TOTAL | $1,069 | $80 |
| Total Assets | $74,887 | $66,027 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 3,443 | 2,270 |
| Accrued Expenses | 719 | 661 |
| Other current liabilities | 351 | 298 |
| TOTAL | $4,513 | $3,228 |
| Non-Current Liabilities | ||
| Other Non-Current Liabilities | 517 | 0 |
| TOTAL | $517 | $N/A |
| Total Liabilities | $5,030 | $3,228 |
| Shareholders' Equity | ||
| Common Shares | 149 | 154 |
| Retained earnings | -43,985 | -54,345 |
| TOTAL | $69,856 | $62,799 |
| Total Liabilities And Equity | $74,886 | $66,027 |